Mission Lucidity - decoding brain disease
Scientific Leadership
Mathieu Vandenbulcke
Director at KU Leuven Brain Institute
Geriatric psychiatrist at UZ Leuven and UPC KU Leuven
Head of the research group Neuropsychiatry at KU Leuven
Chair of the Scientific Committee at Mission Lucidity
Bart De Strooper
Group leader at the VIB-KU Leuven Center for Brain & Disease Research
Director of the UK DRI
Scientific lead at Mission Lucidity
Coordinator of the TRIAGE project
Dries Braeken
R&D Manager Life Science Technologies at imec
Technology lead at Mission Lucidity
Coordinator of the brain organoid project
Patrik Verstreken
Science Director at the VIB-KU Leuven Center for Brain & Disease Research
Coordinator of the brain-on-chip project
Ingeborg Stalmans
Head of the Research Group Ophthalmology at KU Leuven
Ophthalmologist at UZ Leuven
Coordinator of the ADMIRE project
Peter Janssen
Head of the laboratory for Neuro- and psychophysiology at KU Leuven
Coordinator of the TESCOGEN project
Sebastian Haesler
Management Team
Jenny Ceccarini
Program development officer at Mission Lucidity
Chair of the management and fundraising teams
Contact
Tel. +32 16 32 89 60
An Schreurs
Head of communications at Mission Lucidity
Science journalist at UZ Leuven
Contact
Tel. +32 16 34 49 39
Steering Committee
Urbain Vandeurzen
"Neurodegenerative diseases affect numerous people worldwide but despite intensive research, effective treatments are still lacking. As a serial entrepreneur, it is my experience that when world-class researchers that are driven by a compelling vision and ambition, get access to sufficient resources and breakthrough technology, they can achieve what seemingly looked impossible. That is why with Mission Lucidity, we want to create the conditions to fundamentally decode dementia."
Luc Van den hove
“I strongly believe that there is hope for dementia. Thanks to the advances in nanotechnology we can now measure what hasn’t been measured before. We can now develop groundbreaking tools, that allow us gain a profoundly deeper understanding in the disease than ever before. With Mission Lucidity, we have all the expertise from world-renown partners in hand – biomedical, clinical and nanotechnological - to bring hope for dementia.”
Koenraad Debackere
“What makes humans unique? Everyone investigating that question cannot ignore the human brain, the way it developed and functions. We understand what others think given our knowledge of the world. We understand what others cannot know. That lucidity defines us. Unfortunately, it can also fail us. That is why we must decode dementia. To safeguard or give back the lucidity that uniquely defines us.”
Wim Robberecht
“In the next decades, we will be confronted with a tsunami of chronic illnesses due to aging of the population. Mental disorders are responsible for the largest portion of these chronic diseases, with dementia posing the greatest challenge. That is why it must be decoded, to give people back what is their most human characteristic: their lucidity.”
Jérôme Van Biervliet
“Although our understanding of dementia has increased tremendously in the last two decades and despite all the efforts to find new drugs, there is still no cure. The right way forward is a cross-disciplinary initiative that combines the expertise of basic science with disruptive technologies and accelerates translation to patients.”
Other members
Other members of Mission Lucidity's Steering Committee include Jo De Boeck (Chief Strategy Officer at imec), Chris Van Geet (vice rector at KU Leuven), Gert Van Assche (Chief Medical Officer at UZ Leuven) and Wim Goemaere (Chief Operating Officer at VIB)